sKninja
10 años hace
Do you know the amount of people that bought real estate classes, took the exam, passed, pay their realtor fees every year , pay for advertising, cards, a desk, etc. and YET to have listed a HOME..... all the hype and cult talk of commissions from other succcessful realtors..... have you been to a real estate networking meeting?
You call USANA a cult? Have you been to a college football game!?
Listen sounds to me like you have a personal story or you or some friends you now trying something that apparently you disapprove of - but sorry to burst you bubble but network marketing globally is bigger than the MUSIC INDUSTRY worldwide.
Don't be a complainer or a apologists to the reality that success is not easy or EVERYONE would be successful. THere are people successful in USANA, in Real Estate in business in sports, in learning a new language, in learning a new instrument AND there are people that FAIL.
So just because someone fails to succeed you don't blame the opportunity. It works, but not every ONE works.
investora2z
11 años hace
Investors can only be happy with the stock's performance over the last 8 months. It has nearly tripled from the 52 week low made in December 2012. Even on a 52 week basis, it has appreciated by 77%. Even over the longer term, the stock has done well. The fundamentals have remained abreast with the stock price. Last earnings saw the company beating analyst estimates by a huge margin, and revenue and net income increased by 18% and 45% respectively. The earnings guidance for the full year was upped to $5.3-$5.45 per share, and even the revenue estimate was enhanced to $700-$720 million. Consequently the stock got a boost, and momentum increased. Because of the improvement in fundamentals, the valuations remain reasonable even after such a huge rise. The trailing P/E is around 14.7, and the forward P/E is around 13.50. This indicates modest expectations of growth in earnings over the next few quarters. The PEG ratio is 0.82 which indicates expectations of good growth in earnings over the longer term. The price to sales is also not too high at 1.63. The operating margins and the net margins are around 17% and 11% respectively on a ttm basis. The good part is that the company has no debt on books, and it had around $96 million cash on June 29. The supplements and weight management market will continue to grow at a reasonable pace. New innovative products are launched from time to time based on customer needs. Chromadex Corporation (CDXC) had recently launched a vitamin derivative nicotinamide riboside for weight and diabetes management. USNA is known for the safety and quality of its products, and manufactures most of its products in-house. It has received numerous awards for that. USNA has to add new products from time to time to improve the margins and bolster the growth rate. After such a huge rise, it is important that the company meets and exceeds the guidance. However, the shorts data for July 31 is pretty unbelievable.
investora2z
11 años hace
Many analysts have downgraded the stock recently. The consensus rating is hold, and the consensus price target is around $63. It has corrected by 5 odd percent from the highs of $76 a few weeks ago. It had gone through another corrective phase recently, but held crucial levels. The last results helped the stock gain some momentum on the upside, and hence it has remained reasonably strong after that. The revenues had grown by nearly 10%, and the net income had grown by around 30% on a yoy basis. On sequential basis, the performance has not been that good as the revenue growth has slowed down, and the net income is also not growing consistently. Over the longer term the stock performance is decent, with the real appreciation in the stock coming over the last 6-7 months. It has appreciated from ~$31 to ~$76 between December 2012 and June 2013. Even after this rise, the valuations remain okay with a trailing P/E of 14.89 and forward P/E of 12.18. A PEG ratio of 0.75 indicates that there are expectations of good growth from the stock in the medium to long term. The price to sales ratio is 1.48, which is also reasonable. The good part is that it does not have any debt on books, and had about $70 million cash on March 30. Considering this, it looks attractive if looked in isolation. But the key to success is faster growth in revenues and improvement in margins. After such a big rise in the stock, it is important that the financial performance catches up fast. For this, new segments / products need to be explored and molecules researched by other companies need to be kept in mind. Chromadex (CDXC) recently launched Nicotinamide Riboside a new vitamin derivative which is thought to have a lot of potential. USNA should attempt to get new products to bolster growth so that the stock remains strong.
investora2z
12 años hace
The stock has done great for investors over the last 6 months with a 125% return. So far so good, but now it will be good to get a little cautious. The recent results beat expectations, but a closer look indicates that at least the rate of growth is slowing down a bit. The revenue growth was 9.7% on a YoY basis whereas in the last quarter, the growth was 15%. Similarly, the net income growth was 40% in the last quarter compared to around 6% in this quarter. If the guidance for 2013 is taken, the revenue growth is expected to be 8-11% which is lower (at the lower end of the range) than what was achieved last year. So, on an absolute basis, the fundamentals are not doing that great. Analyst estimates have to be given due respect, but over the last few months the stock has done enough to capture a lot of future goodness. However, the valuations are still great with low price to earnings and price to sales ratio. Low PEG also indicates expectations of good growth. In any case, correction is becoming due and one can work with trailing stop losses. Further, the markets are also due for some correction, and that could be another trigger for the stock to come down a little. For maintaining future growth, especially in the focus market of greater China region, it is important for USNA to develop / acquire new products / companies on a local and global basis. Smaller companies like Chromadex Corporation (CDXC) are doing great with a healthy pipeline of innovative products. Investors like Dr Robert Frost, Michael Brauser and Barry Honig have increased stake in Chromadex due to the potential of the product. The multi-billion dollar nutrition / supplements industry is supported by ingredient makers like Chromadex. USNA has to remain open to new ideas and products / segments to maintain its future growth.
investora2z
12 años hace
USNA recently announced that CoQuinone 30 has been evaluated and approved by ConsumerLab.com LLC, a leading provider of independent product test results. The labeled amount of CoQ10 was confirmed in the tests. The company has been recently named the No. 1 rated brand in direct sales based on customer satisfaction from ConsumerLab.com's 2013 Survey of Vitamin and Supplement users. Meanwhile, the stock didn't do much on Friday, and remained flat at around $46. The recent recovery from the end December lows (~$31) has been extremely brisk with a 50% rise coming in less than three months. Thus, the bounce was stronger than the fall of 30% in December. The stock still trades above the short term averages, and the lower volumes indicate the possibilities of a breather being taken. It is doing okay on the fundamental front with growth in sales and net income. Compared with 2011, the net income increased to $ 66.4 million (~31% increase). Despite the recent rise, the stock is trading with a low price to earnings multiple of around 10 which is great for a company with zero debt on books. The market for dietary supplements and nutritional / personal care products is increasing in size, and the growth has been reasonable. Several smaller companies e.g. MusclePharm (MSLP) are growing at an exponential pace with sales growing from $1 million to 78 million in 3 years. For companies like USNA, the key to sustained growth is development of new products, and keeping the eyes open for inorganic growth through acquisition for smaller companies / successful brands. With its success in the industry, USNA can identify such players and products which have tremendous potential, offer synergies or complement the existing offerings of USNA. Of course, the cost structure has to remain efficient to enable the company to remain debt free and be able to fund its growth endeavors.
MWM
12 años hace
Is USANA Health Sciences A Better Short Than Herbalife?
Dec 26, 2012 | by LongShort 101 | about:USNA
include:HLF
Last week was an eventful one for the multilevel marketing space in the public markets, to say the least. But lost in all of the headlines surrounding Bill Ackman's devastating short thesis on Herbalife (HLF) were some even more jaw-dropping developments at peer company USANA Health Sciences (USNA). On December 14th, USANA announced the resignation of both its COO and CFO and promoted to the role of CFO its Vice President of Human Resources, someone who has spent most of his career in HR and who has very limited finance experience. And while the former CFO's resignation was tied to "family health matters," no such reason - or any reason whatsoever, for that matter - was given for the concurrent resignation of the COO; the timing here is all the more unusual given that he had been touted and lavishly praised in a company press release less than two months ago. And all this comes only 19 months after the previous CFO, COO, and two other top executives resigned under even more troubling circumstances that are discussed in detail below.
But most shocking of all is that in the three days prior to the announcement of the management changes, Myron Wentz, the founder and chairman of the company, sold 471,050 shares, or more than $20M of stock. While Wentz has been a consistent seller of USANA shares for the past 5 months, these sales were done in different and dramatic fashion: his sales represented an incredible 49% of all the volume traded in the stock over those three days.[1] And so with management fleeing for the exits - their resumes and wallets in hand - and with the recent furor over Herbalife, it seems like an appropriate time to revisit the USANA short thesis, which I believe to be even stronger than Ackman's case against Herbalife.
First and foremost, the central components of what Ackman argues against Herbalife hold for USANA as well, with even less burden of proof. As Ackman emphasizes (see page 60 of his presentation), the FTC's position on multilevel marketing is that an "organization is deemed a pyramid scheme if the participants obtain their monetary benefits primarily from recruitment rather than the sale of goods and services to consumers." Ackman's core argument as to why Herbalife is an illegal pyramid scheme is that it violates this rule by having over 50% of its revenue come from recruiting, a rule which Herbalife is clearly aware of (page 61). While Ackman has to make several well-substantiated assumptions to prove that Herbalife, despite its claims to the contrary, violates this criterion, USANA presents us with no such difficulties. In 2011, USANA reported total revenue of $581.9M. According to USANA's 2011 10-K, 90% of this revenue comes from active distributors. USANA does not provide an estimate of what retail margin is in its financial statements, as Herbalife does, but it is easy enough to calculate what this figure would be by looking at USANA's U.S. price list, which reveals that "retail" prices are at most 20% greater than wholesale distributor prices. Even if one assumes that all products USANA distributors sell are sold at the full 20% retail markup, distributors' margin on that $523.7M of product sales would be a mere $104.7M.[2] At the same time, associate incentives, which USANA helpfully publishes in a single expense line item, totaled $265.9M in 2011.[3] This means that by USANA's own numbers, associate incentives are a whopping 72% of total participant monetary benefit, well above the FTC's pyramid scheme threshold of 50%.[4]
But unlike Herbalife, the regulatory and business risk for USANA doesn't stop with the FTC. USANA generates 36.2% of its revenues and likely a disproportionate amount of its profits from the Greater China region, despite the fact that China has made all forms of multilevel marketing explicitly illegal since 2005 (see the People's Republic of China State Council Directive #444, Prohibiting Multilevel Marketing). USANA has always claimed that it is operating as a legal "direct seller" in China, but as the recent detailed report by Citron Research has made clear, the Hong Kong branch of USANA is seemingly actively recruiting mainland Chinese to join the standard multilevel USANA organization.
Remarkably, the company has actually implied internally that its operations are at odds with Chinese law. On May 8th, 2011, the company sent a letter to its Hong Kong distributors announcing policy changes whose deliberate intent was to make signing up mainland Chinese citizens in Hong Kong in absentia effectively impossible "to make sure that in China we have [a great] reputation with all governing bodies." Only five days later on May 13th - immediately following the resignations of the then COO, CFO, VP of Sales, and VP of Finance - the company issued another letter to its Hong Kong distributors canceling the announced changes.
The company has taken no steps since to re-establish the policy changes outlined in the May 8th letter. With the Chinese government, which has long turned a blind eye to MLM activity, increasingly cracking down on multilevel marketing schemes and even arresting local USANA distributors, USANA is stuck between a rock and a hard place - if the company removes the MLM compensation scheme from its China operations, its distributors will flee to one of many competitors, but if it continues with business as usual, it will eventually face the heavy hand of the Chinese government. It is likely only a matter of time before USANA is kicked out of, or faces dramatic decline in, its second-largest market.
So in USANA you have a $500M (!) market cap company that is potentially violating both U.S. and Chinese laws (the U.S. and Greater China together currently account for 60% of the company's revenues) and a $500M (!) market cap company that has the son of the founder as the CEO, no active COO, a former head of HR as its current CFO, and someone without a college degree as its new CIO (whom USANA initially reported as having a degree). Perhaps it shouldn't be surprising then that the founder and controlling shareholder would risk federal prosecution to aggressively dump his shares in the company less than 24 hours ahead of public disclosure of material news.
Herbalife is down more than 35% since Ackman exposed the company for potential violations of U.S. law. USANA is down only 15% over that period of time. With the added problems of a punchline for a management team and Chinese regulatory risk beginning to boil over, it sure feels as though some catch-up, at a minimum, is in order. And as it would seem to be almost impossible for Herbalife to be found in violation of federal law without similar repercussions for USANA, USANA offers less crowded exposure to the Ackman short thesis with additional ways of getting paid even if the FTC doesn't act.
[1] How does someone sell that much stock without the share price collapsing? I'd suspect that the company was particularly active with its buyback program those very same days.
[2] The Hong Kong price list does show a retail margin of as much as 33% for autoshipped orders, but our 20% assumption is still likely very conservative given the disclosure in the 2011 10-K that only 35% of sales are autoshipped; the FTC threshold is relevant only for the U.S. market, for which the margin is at most 20%; and even if the retail margin for the U.S. were 33% and not 20%, USANA would still violate the FTC threshold with associate incentives amounting to 61% and not 72% of total participant monetary benefit.
[3] This is probably an understated figure - just as Ackman suggests with Herbalife, USANA likely stuffs a good deal of non-monetary associate incentives in the SG&A expense line. As the company reports in its 2011 10-K, "selling, general and administrative expenses include…Associate event costs." And there are plenty of these at USANA. The company takes its top distributors on all-expense-paid vacations to luxurious destinations such as Paris and the Caribbean - see photos of their trips here! - and even supplied its ordinary distributors with free iPads at its annual convention.
[4] Even if you assume the entire amount of USANA's other 10% of revenue (direct sales from USANA to non-distributors) is somehow distributed to participants as a monetary benefit at 100% margin, you'd still be left with 62% of participant compensation coming from recruitment.
Disclosure: I am short USNA. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure: The firm I work for has a significant short position in USNA. We may change our views about, or investment positions in, USNA at any time for any reason, including within the next 72 hours. This is not investment advice or a recommendation to buy or sell any securities, nor is it purporting to provide legal advice to anyone. The article is based only on publicly available information about USNA and therefore could be incomplete. We make no representation or warranty, express or implied, as to the accuracy or completeness of the article. Readers should review the cited sources and other related materials and reach their own conclusions. Readers should consult their own investment and legal counsel on the subjects discussed here before making any investment decisions.
Get push notifications on USNA
3 Comments
$toney
14 años hace
USNA News: Innovative Nutritional Hybrid Technology Introduced at USANA International Convention
Date : 09/13/2010 @ 2:33PM
Source : PR Newswire
Innovative Nutritional Hybrid Technology Introduced at USANA International Convention
Usana Health Sciences Inc. (MM) (NASDAQ:USNA)
USANA Health Sciences (Nasdaq: USNA), a leader in nutritional supplement manufacturing, today announced that it will be one of the first companies in the industry to utilize Nutritional Hybrid Technology. This cutting-edge manufacturing method was unveiled to thousands of USANA independent Associates in attendance at the company's international convention.
"USANA is proud to be a leader in the evolution of nutrition technology," said Dr. Tim Wood, USANA Executive Vice President of Research and Development. "USANA's Nutritional Hybrid Technology illustrates our commitment to innovative manufacturing practices and production of high-quality nutritional products."
Through Nutritional Hybrid Technology, USANA can now combine two distinct formulas into one bilayered tablet, allowing for advanced ingredient combinations while providing product stability. The technology will also help consumers simplify their nutritional regimen by decreasing the number of tablets they take each day. Two new USANA formulas, Proflavanol® C100 and Hepasil DTX™, were created with the new manufacturing technology and also unveiled at the company's convention.
Proflavanol C100 combines powerful proanthocyanidins from grape-seed extract with high-potency vitamin C to promote sound cardiovascular health, immune function, and healthy-looking skin. An in-house USANA study found that the combination of grape-seed extract and vitamin C in Proflavanol C100 provides long-term antioxidant activity and better protective effects than if they were not combined.
USANA's upgraded Hepasil DTX formula contains a proprietary blend of ingredients to maintain optimum liver support and aid in the body's detoxification processes. Nutritional Hybrid Technology allows USANA to boost key ingredients in the supplement while maintaining product quality and stability.
Learn more about USANA's products and opportunity by visiting our Web site, reading our blog, becoming a fan on Facebook, or following us on Twitter.
About USANA: USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, energy and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, the Philippines, Mexico, the Netherlands and the United Kingdom.
$toney
14 años hace
USANA News: Innovative Nutritional Hybrid Technology Introduced at USANA International Convention
Date : 08/26/2010 @ 7:35PM
Source : Business Wire
Innovative Nutritional Hybrid Technology Introduced at USANA International Convention
Usana Health Sciences Inc. (MM) (NASDAQ:USNA)
Intraday Stock Chart
Today : Friday 27 August 2010
USANA Health Sciences (NSDQ: USNA), a leader in nutritional supplement manufacturing, today announced that it will be one of the first companies in the industry to utilize Nutritional Hybrid Technology. This cutting-edge manufacturing method was unveiled to thousands of USANA independent Associates in attendance at the company’s international convention.
“USANA is proud to be a leader in the evolution of nutrition technology,” said Dr. Tim Wood, USANA Executive Vice President of Research and Development. “USANA’s Nutritional Hybrid Technology illustrates our commitment to innovative manufacturing practices and production of high-quality nutritional products.”
Through Nutritional Hybrid Technology, USANA can now combine two distinct formulas into one bilayered tablet, allowing for advanced ingredient combinations while providing product stability. The technology will also help consumers simplify their nutritional regimen by decreasing the number of tablets they take each day. Two new USANA formulas, Proflavanol® C100 and Hepasil DTX™, were created with the new manufacturing technology and also unveiled at the company’s convention.
Proflavanol C100 combines powerful proanthocyanidins from grape-seed extract with high-potency vitamin C to promote sound cardiovascular health, immune function, and healthy-looking skin. An in-house USANA study found that the combination of grape-seed extract and vitamin C in Proflavanol C100 provides long-term antioxidant activity and better protective effects than if they were not combined.
USANA’s upgraded Hepasil DTX formula contains a proprietary blend of ingredients to maintain optimum liver support and aid in the body’s detoxification processes. Nutritional Hybrid Technology allows USANA to boost key ingredients in the supplement while maintaining product quality and stability.
Learn more about USANA’s products and opportunity by visiting our Web site, reading our blog, becoming a fan on Facebook, or following us on Twitter.
About USANA: USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, energy and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, the Philippines, Mexico, the Netherlands and the United Kingdom.
$toney
14 años hace
Almost forgot: USANA Health Sciences Acquires BabyCare Ltd, a Direct Selling Company in China
Date : 08/16/2010 @ 5:03PM
Source : Business Wire
Stock : USANA Health Sciences, Inc. (USNA)
Quote : 44.45 1.26 (2.92%) @ 4:26PM
USANA Health Sciences Acquires BabyCare Ltd, a Direct Selling Company in China
Usana Health Sciences Inc. (MM) (NASDAQ:USNA)
Historical Stock Chart
1 Month : July 2010 to August 2010
USANA Health Sciences, Inc. (NASDAQ: USNA) today announced that it has acquired BabyCare Ltd, a China-based direct selling company that develops, manufactures and sells nutritional products for the entire family, with an emphasis on infant nutrition. Founded in 1999, privately held BabyCare Ltd is headquartered in Beijing, China, with operations in 21 cities and 16 provinces. BabyCare’s products are sold through a growing distributor sales force, utilizing a commission-based compensation plan under a license to engage in direct selling activities in the Municipality of Beijing. BabyCare is working to obtain similar licenses in the other provinces in which it operates. This direct selling license allows BabyCare to engage non-employee distributors to sell BabyCare’s products, apart from the company’s traditional service centers.
Dave Wentz, USANA’s chief executive officer, said, “We are very excited about this acquisition and the opportunity that it provides for USANA to ultimately establish a business via BabyCare in China. BabyCare is a natural fit for us, as they share our philosophy for high-quality products and pristine manufacturing practices. In fact, 15 of BabyCare’s nutritional supplement products are qualified by SFDA, the Government’s highest level of product regulatory approval. As a company with over 11 years of in-country experience, and as one of only 25 companies operating with a direct selling license in China, BabyCare brings us both valuable knowledge of China’s direct selling market and the ability to expand our business in China via BabyCare. We believe this acquisition is the most effective way for us to enter this enormous market.”
USANA’s objective for this acquisition in the short-term is to gain familiarity and expertise in the Chinese direct selling market. As such, during the next 18 to 24 months, BabyCare will continue to operate as a standalone business in China. USANA believes that its direct selling expertise will assist BabyCare in generating incremental growth by reaching additional customers through an increased number of distributors selling their products. USANA’s long-term objective for this acquisition, however, is to establish and grow the USANA brand throughout China. In an effort to drive this long-term objective, USANA is already working to license some of its products to BabyCare to enhance BabyCare’s product line.
The acquisition of BabyCare was accomplished by acquiring Pet Lane Inc., a Delaware corporation, who is the parent company of BabyCare in China. The transaction was entered into and closed according to the definitive terms of a share purchase agreement. The purchase price for the shares consisted of $45 million in cash and 400,000 shares of USANA stock. The details of the transaction will be filed shortly in Forms 8-K.
USANA’s chief financial officer, Jeff Yates, said, “BabyCare provides USANA with an excellent entry point into this significant direct selling market. With 2009 annual net sales of approximately $15 million and total assets of $19 million, this operation provides a solid platform for future growth. Historically, BabyCare has not been profitable under its retail-based model, but is in the process of transitioning to operate under its direct selling license. Through BabyCare, residents of China, who have been interested in USANA, now have a significant opportunity to build a direct selling business in China. Considering this opportunity, coupled with BabyCare’s established infrastructure, experienced management team and core customer base, we expect BabyCare’s sales to increase much faster than they have historically.”
Conference Call
USANA will hold a conference call and webcast to discuss this announcement with investors on Tuesday, August 17, 2010 at 9:00 a.m. Eastern Time. Investors may listen to the call by dialing 877-941-2930 or accessing USANA’s investor website at http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high quality nutritional, personal care and weight management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
$toney
14 años hace
USNA NEWS - Warehouse Control System by QC Software Allows USANA to Increase Capacity by 300 Percent
Cincinnati, OH -- (SBWIRE) -- 08/06/2010 -- Dr. Myron Wentz founded USANA Health Sciences in 1992 in Salt Lake City, Utah. USANA is a direct selling company that develops and manufactures high-quality nutritional, weight management, and personal-care products. USANA has experienced several years of record growth and USANA has expanded internationally and currently operates in 14 markets throughout Asia, the Americas, Australia and Europe. With annual net sales exceeding $430 million, USANA has become a leader in the industry.
USANA’s management team recognized the need to increase capacity and improve efficiency at their Utah distribution facility. Their manual process was too costly and inefficient, and they had to find new ways to remain competitive in the global economy. After careful consideration, QC Software’s Warehouse Control System (WCS) was chosen to manage the facility’s order fulfillment operation because it was a proven, cost-effective solution. The goals were to improve material flow and the overall throughput of the material handling system; improve the accuracy of the order fulfillment process; improve productivity; and support future growth and expansion.
Phase I was completed with the implementation of QC Navigator to manage the real-time activities of the equipment and QC OMS (Order Management System) to facilitate order fulfillment.
The 20,000 square foot distribution facility now processes 5,000 - 7,000 orders per day, and has the capability of shipping 21,000 orders every day. Features such as cartonization, wave planning, and a new line dedicated to small orders optimized their operation and lowered costs. After the WCS implementation, order fulfillment was reduced from a 24/7 operation down to two eight-hour shifts for five days per week. Since the system is faster and more efficient, the number of employees needed was cut in half and order capacity increased 300 percent.
According to Jim Brown, VP of Operations, “USANA is dedicated to implementing green initiatives, and we are proud to be working with a company that has the same goals. We are grateful that QC Software has provided USANA with valuable tools to continue our mission to protect and preserve the environment.”
In 2009, as part of their green initiative, USANA looked for additional ways to improve efficiency and reduce their environmental impact. The conveyor system was not designed to accommodate small packaging, so employees had to either manually repack these orders or ship them in larger containers. Since both of these solutions were inefficient, QC Software developed a new process to separate these orders from the regular pool. USANA then added a third line dedicated to smaller, non-conveyable orders, which reduced waste, lowered costs and further enhanced picking efficiency. Packages continued to be shipped in a timely manner without increasing labor costs. Brown estimated the company saved about 2,188 kilograms, or 2.2 metric tons, of cardboard in the first six months of operation. Using the pick-to-light system, barcode technology and quality checks, USANA was able to achieve a 99% order accuracy rate.
QC Software (http://www.qcsoftware.com) is the leading provider of Tier 1 warehouse control systems to the warehousing and distribution industries.
QC Software, Inc.
http://www.qcsoftware.com
Jerry List
JerryList@qcsoftware.com
513-469-1424
Media Relations Contact
Jerry List
Queen City Software, Inc.
Telephone: 513-469-1424
Email: Click to Contact Jerry List By Email
Website: http://www.qcsoftware.com
Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Monksdream
5 meses hace
Wobby
4 años hace
Rawnoc
12 años hace
Penny Roger$
13 años hace
Tina
14 años hace
Hot Features
Premium
